OBJECTIVE: To identify potential missed opportunities and to suggest interventions for cervical cancer screening in members of a prepaid health plan by examining the membership histories and medical records of women who had no Pap smear performed in the 3 years prior to the diagnosis of ICC. METHODS: Medical records of all 642 members of a prepaid health plan developing ICC during the period from 1988 to 1994 were reviewed and details of patient interaction with the health care system were abstracted. Assessment of screening history and history of clinic visits was limited to the period 36 months prior to diagnosis, but excluded the last 6 months prior to diagnosis, so as to avoid including smears or visits which were part of the evaluation that led to the recognition of ICC. RESULTS: Of women developing ICC, 384/642 (60%) had not had a smear in the period from 36 months to 6 months preceding the diagnosis. Of these 384 unscreened women, 241 (63%) had been insured by our HMO for at least 30 of the 36 months prior to diagnosis. Contact with the medical system in one of the primary care outpatient clinics was documented in 180/241 (75%) of these long-standing members during the specified period. Considering only Internal Medicine and Family Practice clinic visits, 169/241 (70%) had been seen at least once and 101/241 (42%) had been seen 3 or more times. CONCLUSION: Most long-standing HMO members developing ICC without benefit of recent Pap smear screening were seen in primary care outpatient clinics in the 3 years preceding their diagnosis. Copyright 1998 Academic Press.
OBJECTIVE: To identify potential missed opportunities and to suggest interventions for cervical cancer screening in members of a prepaid health plan by examining the membership histories and medical records of women who had no Pap smear performed in the 3 years prior to the diagnosis of ICC. METHODS: Medical records of all 642 members of a prepaid health plan developing ICC during the period from 1988 to 1994 were reviewed and details of patient interaction with the health care system were abstracted. Assessment of screening history and history of clinic visits was limited to the period 36 months prior to diagnosis, but excluded the last 6 months prior to diagnosis, so as to avoid including smears or visits which were part of the evaluation that led to the recognition of ICC. RESULTS: Of women developing ICC, 384/642 (60%) had not had a smear in the period from 36 months to 6 months preceding the diagnosis. Of these 384 unscreened women, 241 (63%) had been insured by our HMO for at least 30 of the 36 months prior to diagnosis. Contact with the medical system in one of the primary care outpatient clinics was documented in 180/241 (75%) of these long-standing members during the specified period. Considering only Internal Medicine and Family Practice clinic visits, 169/241 (70%) had been seen at least once and 101/241 (42%) had been seen 3 or more times. CONCLUSION: Most long-standing HMO members developing ICC without benefit of recent Pap smear screening were seen in primary care outpatient clinics in the 3 years preceding their diagnosis. Copyright 1998 Academic Press.
Authors: Colin Malone; Jasmin A Tiro; Diana Sm Buist; Tara Beatty; John Lin; Kilian Kimbel; Hongyuan Gao; Chris Thayer; Diana L Miglioretti; Rachel L Winer Journal: J Med Screen Date: 2019-11-20 Impact factor: 2.136
Authors: Jennifer S Smith; Noel T Brewer; Debbie Saslow; Kenneth Alexander; Mildred R Chernofsky; Richard Crosby; Libby Derting; Leah Devlin; Charles J Dunton; Jeffrey Engle; Maria Fernandez; Mona Fouad; Warner Huh; Walter Kinney; Jennifer Pierce; Elena Rios; Mitchel C Rothholz; Judith C Shlay; Rivienne Shedd-Steele; Sally W Vernon; Joan Walker; Theresa Wynn; Gregory D Zimet; Baretta R Casey Journal: Cancer Causes Control Date: 2013-07-05 Impact factor: 2.506
Authors: Rachel L Winer; Jasmin A Tiro; Diana L Miglioretti; Chris Thayer; Tara Beatty; John Lin; Hongyuan Gao; Kilian Kimbel; Diana S M Buist Journal: Contemp Clin Trials Date: 2017-11-04 Impact factor: 2.226
Authors: Sandi L Pruitt; Claudia L Werner; Eric K Borton; Joanne M Sanders; Bijal A Balasubramanian; Arti Barnes; Andrea C Betts; Celette Sugg Skinner; Jasmin A Tiro Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-09-05 Impact factor: 4.254
Authors: Colin Malone; Diana S M Buist; Jasmin Tiro; William Barlow; Hongyuan Gao; John Lin; Rachel L Winer Journal: Prev Med Date: 2020-12-31 Impact factor: 4.018